Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

BACKGROUND: Antibody-based therapies for respiratory viruses are of increasing importance. The INSIGHT 006 trial administered anti-influenza hyperimmune intravenous immunoglobulin (Flu-IVIG) to patients hospitalized with influenza. Flu-IVIG treatment improved outcomes in patients with influenza B bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanderven, Hillary A., Wentworth, Deborah N., Han, Win Min, Peck, Heidi, Barr, Ian G., Davey, Richard T., Beigel, John H., Dwyer, Dominic E., Jain, Mamta K., Angus, Brian, Brandt, Christian T., Mykietiuk, Analia, Law, Matthew G., Neaton, James D., Kent, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443807/
https://www.ncbi.nlm.nih.gov/pubmed/37289541
http://dx.doi.org/10.1172/jci.insight.167464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443807/
https://www.ncbi.nlm.nih.gov/pubmed/37289541
http://dx.doi.org/10.1172/jci.insight.167464

Ejemplares similares